CONTEXT: Muir-Torre syndrome is a rare autosomal dominant genodermatosis caused by mutations in the mismatch repair genes. It is characterized by the presence of sebaceous skin tumors and internal malignancies, affecting mainly the colon, rectum and urogenital tract. Awareness of this syndrome among physicians can lead to early diagnosis of these malignancies and a better prognosis. CASE REPORT: We report the case of a Chilean patient who, over the course of several years, had multiple skin lesions, endometrial cancer and colon cancer. The syndrome was diagnosed using molecular techniques such as microsatellite instability analysis, immunohistochemistry and DNA sequencing, which allowed us to find the causative mutation. CONCLUSION: Molecular diagnostics is a highly useful tool, since it allows clinicians to confirm the presence of mutations causing Muir-Torre syndrome. It is complementary to the analysis of the clinical data, such as dermatological presentation, presence of visceral malignancies and family history of colorectal tumors, and it provides important knowledge to help physicians and patients choose between treatment options.
and MSH2 protein expression was studied by means of immunohistochemistry with monoclonal antibodies. Lack of hMSH2 expression was found (Figure 2 ), while hMLH1 was expressed normally (data not shown). Also, DNA from the patient's colon cancer was tested for microsatellite instability, using the markers BAT25, BAT26, D2S123, D5S346 and D17S250. 8 The tumor was MSI-high, since it presented over 30% unstable loci. In this analysis, both mononucleotide loci (BAT25 and BAT26) were unstable (Figure 3) , which is evidence of mismatch repair system malfunctioning. 
DISCUSSION
Muir-Torre syndrome is a rare form of Lynch syndrome and is characterized by tumors of the sebaceous glands or keratoacanthoma and a median age of onset of 50 years. Molecularly, Muir-Torre has a common etiology with Lynch syndrome: germline mutations in the mismatch repair genes.
However, different studies have shown that Muir-Torre syndrome is preferentially associated with mutations in the hMSH2 gene, [1] [2] [3] 7 although mutations in hMLH1 and hMSH6 can also be implicated. 9, 10 The mutation found in our patient generated a premature stop codon, which produced a truncated MSH2 protein that lacks an important functional domain. 7, 11 This syndrome has also been associated with mutations in the MYH gene, which is inherited in an autosomal recessive Lynch syndrome accounts for approximately 3% of the incidence of colon cancer worldwide, and can also present with cancer of the urogenital tract, stomach, small bowel, brain and hepatobiliary tract. 5, 6 It is caused by germline mutations in genes of the mismatch repair system, mainly hMSH2 and hMLH1. Molecularly, interferon has been used to prevent some of the cutaneous neoplasms that have been described. 18, 19 Furthermore, use of prophylactic surgery versus endoscopic monitoring has been widely discussed. In patients with colon cancer and proven mutations, total colectomy is recommended, due to the high risk of synchronous and metachronous tumors. However, in patients suspected of having Muir-Torre syndrome, with colon cancer but without a genetic diagnosis, Figure 3 . Microsatellite instability analysis. use of prophylactic surgery is controversial. 20 Women with MuirTorre syndrome are also at higher risk of endometrial and ovarian cancer. In women of childbearing age, total hysterectomy with salpingo-oophorectomy has been discussed as a prophylactic approach, but there is no consensus on this topic.
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CONCLUSION
Molecular confirmation of Muir-Torre syndrome and Lynch syndrome is an important tool in clinical diagnosis, because it allows discrimination between non-carriers, who do not have an elevated risk of internal or skin malignancies, and mutation carriers, who need strict surveillance in every organ affected by the syndrome.
